Objective

2

To evaluate the clinical efficacy of Qingkailing injection in the treatment of children with sepsis and heat syndrome， and investigate its anti-inflammatory， anticoagulant and protective effects.

Method

2

Eighty patients were randomly divided into control group and observation group with forty cases in each group according to the number table. Both groups received comprehensive treatment measures such as fluid resuscitation， anti-infection， anti-inflammatory， anticoagulation， vasoactive drugs， and protection of vital organ functions. While patients in observation group additionally took Qingkailing injection， 5-10 mL each time， intravenous drip after dilution， 1 time/day. Treatment course was five days in both groups. Before and after treatment， the scores of quick sequential organ failure assessment （qSOFA）， pediatric critical illness score （PCIS） and acute physiology and chronic health evalution Ⅱ （APACHEⅡ） were graded； procalcitonin （PCT）， serum amyloid A protein （SAA） before and after treatment， heparin-binding protein （HBP）， tumor necrosis factor-

α

（TNF-

α

）， high-sensitivity C-reactive protein （hs-CRP）， interleukin-6 （IL-6）， IL-10， N-terminal brain sodium Peptide precursor （NT-proBNP）， high-sensitivity cardiac troponin T （hs-cTnT） level， cardiac troponin I （cTnI）， creatine kinase isoenzyme （CK-MB），

D

-dimer （

D-

D ）， fibrinogen （FIB） and antithrombin Ⅲ （AT-Ⅲ） levels were detected.

Result

2

The APACHEⅡ and qSOFA scores in the observation group were lower than those in the control group （

P

<

0.05）， while the PCIS score was higher than that in the control group （

P

<

0.05）. The levels of PCT， SAA，HBP，TNF-

α

， hs-CRP and IL-6 in the observation group were lower than those in the control group （

P

<

0.01）， while the IL-10 level was higher than that in the control group （

P

<

0.01）. The levels of NT-proBNP， hs-cTnT， cTnI， CK-MB，

D

-D and FIB in the observation group were lower than those in the control group （

P

<

0.01）， while the AT-Ⅲ activity was higher than that in the control group （

P

<

0.01）.

Conclusion

2

Qingkailing injection as the adjuvant therapy in children with sepsis and fever syndrome， can play the role of anti-inflammatory， anticoagulant， reducing infection and myocardial damage， thereby reducing the severity of the disease and improving the prognosis.